Advertisements


Marker Therapeutics reports interim results of MultiTAA T Cell Therapy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 21st, 2019

WuXi Biologics Reports Outstanding Interim Results

52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million Net Profit Increased 80.1% Year-on-Year to RMB449.5 Milli.....»»

Category: earningsSource: benzingaAug 19th, 2019

WuXi AppTec Reports First Half 2019 Interim Results

Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB 1,179 Million .....»»

Category: earningsSource: benzingaAug 19th, 2019

Plus Therapeutics Reports Q2 2019 Financial and Business Results

AUSTIN, Texas, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ:PSTV) (the "Company") today announced Q2 2019 financial results and provided updates on corporate activities. Q2 201.....»»

Category: earningsSource: benzingaAug 15th, 2019

Gran Colombia Gold Reports Second Quarter and First Half 2019 Results; Raises 2019 Production Guidance and On Track to Meet 2019 Cost Guidance

TORONTO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Gran Colombia Gold Corp. (TSX:GCM, OTCQX:TPRFF) announced today the release of its unaudited interim condensed consolidated financial statements and accompanying managemen.....»»

Category: earningsSource: benzingaAug 14th, 2019

Neuralstem Reports Second Quarter 2019 Fiscal Results

GERMANTOWN, Md., Aug. 14, 2019 /PRNewswire/ -- Neuralstem, Inc. (NASDAQ:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule technologies, report.....»»

Category: earningsSource: benzingaAug 14th, 2019

Crinetics Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrin.....»»

Category: earningsSource: benzingaAug 13th, 2019

Sabina Gold & Silver Announces Interim Financial Results for The Quarter Ended June 30, 2019

VANCOUVER, British Columbia, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Sabina Gold & Silver Corp. ("Sabina") or (the "Company") (SBB – TSX/SGSVF – OTCQX) reports the interim financial results for the quarter ended June 30, 2018. "During the quarter.....»»

Category: earningsSource: benzingaAug 12th, 2019

Emmaus Life Sciences Reports Sharply Improved 2019 Second Quarter Financial Results

TORRANCE, Calif., Aug. 12, 2019 /PRNewswire/ -- Emmaus Life Sciences, Inc. (NASDAQ:EMMA), a leader in sickle cell disease treatment, today reported significantly improved financial results at its EMI Holdi.....»»

Category: earningsSource: benzingaAug 12th, 2019

Applied Therapeutics Reports Second Quarter 2019 Financial Results

NEW YORK, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company developing novel drug candidates in indications of high unmet medical need, today reported financial results for t.....»»

Category: earningsSource: benzingaAug 12th, 2019

Akero Therapeutics Reports Recent Highlights and Second Quarter 2019 Financial Results

SAN FRANCISCO, Aug. 12, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and .....»»

Category: earningsSource: benzingaAug 12th, 2019

Entasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update

WALTHAM, Mass., Aug. 12, 2019 .....»»

Category: earningsSource: benzingaAug 12th, 2019

Aptevo Therapeutics Reports Second Quarter 2019 Financial Results

Reports Positive Preliminary Top-Line Safety Data for APVO210Phase 1 Single Ascending Dose (SAD) Clinical Study Advances APVO210 into Phase 1 Multiple Ascending Dose (MAD) Study Co.....»»

Category: earningsSource: benzingaAug 9th, 2019

Gemphire Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company d.....»»

Category: earningsSource: benzingaAug 9th, 2019

Galectin Therapeutics Reports Q2 2019 Financial Results and Provides Business Update

NORCROSS, Ga., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today rep.....»»

Category: earningsSource: benzingaAug 9th, 2019

Ritchie Bros. reports second quarter 2019 results, raises dividend and announces interim Co-Chief Executive Officers

VANCOUVER, Aug. 8, 2019 /CNW/ - Ritchie Bros. Au.....»»

Category: earningsSource: benzingaAug 8th, 2019

Marker Therapeutics reports Q2 EPS (12c), consensus (13c)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2019

Bellerophon Provides Business Update and Reports Second Quarter 2019 Financial Results

WARREN, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) ("Bellerophon" or t.....»»

Category: earningsSource: benzingaAug 8th, 2019

Bayer buys BlueRock in $600 million bet on stem cell therapies

German drugmaker Bayer is paying up to $600 million for full control of cell therapy developer BlueRock Therapeutics, stepping up investment in a promising new medical area to revive its drug development pipeline......»»

Category: topSource: reutersAug 8th, 2019

Knight Therapeutics Reports Second Quarter 2019 Results

MONTREAL, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ("Knight"), a Canadian specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2019. All.....»»

Category: earningsSource: benzingaAug 8th, 2019

H/Cell Energy Reports FY2019 Second Quarter Financial Results

DALLAS, Aug. 07, 2019 (GLOBE NEWSWIRE) -- H/Cell Energy Corporation (OTCQB-HCCC) ("HCCC"), a company that designs and implements clean energy solutions fe.....»»

Category: earningsSource: benzingaAug 7th, 2019